Generic placeholder image

Current Pharmaceutical Design

Author(s): Fatemeh Forouzanfar, Ali Forouzanfar, Thozhukat Sathyapalan, Hossein M. Orafai and Amirhossein Sahebkar*

DOI: 10.2174/1381612826666200513112607

DownloadDownload PDF Flyer Cite As
Curcumin for the Management of Periodontal Diseases: A Review

Page: [4277 - 4284] Pages: 8

  • * (Excluding Mailing and Handling)

Explore Articles
About Journal
For Authors
For Editors
For Reviewers

Abstract

Periodontal disease is one of the most common causes of tooth loss among adults. Research shows that inflammation is one of the crucial components in the initiation and progression of periodontitis. Various herbal medicines have recently been receiving attention for the management of periodontitis owing to their general safety and efficacy. Curcumin, a bioactive polyphenol extracted from Curcuma longa, has been shown to possess antioxidant, antimicrobial, anti-inflammatory and analgesic properties. Several studies have assessed the efficacy of curcumin against periodontal diseases. These studies have shown equivalent or even higher efficacy of curcumin compared to the commonly used medications for the management of periodontitis such as chlorhexidine. Herein, we review the experimental and clinical findings on the anti-periodontitis effects of curcumin and the pharmacological mechanisms underlying these effects.

Keywords: Inflammation, gingivitis, herbal medicine, curcumin, periodontitis, herbal mouthwash.

[1]
Sheiham A. Oral health, general health and quality of life. SciELO Public Health 2005; 83(9): 644.
[2]
Petersen PE, Ogawa H. The global burden of periodontal disease: Towards integration with chronic disease prevention and control. Periodontol 2000 2012; 60(1): 15-39.
[http://dx.doi.org/10.1111/j.1600-0757.2011.00425.x] [PMID: 22909104]
[3]
Najafi MH, Taheri M, Mokhtari MR, et al. Comparative study of 0.2% and 0.12% digluconate chlorhexidine mouth rinses on the level of dental staining and gingival indices. Dent Res J (Isfahan) 2012; 9(3): 305-8.
[PMID: 23087736]
[4]
Ghanbari H, Forouzanfar A, Fatemi K, et al. Modified widman flap procedure: With or without periodontal dressing? Open J Stomatology 2012; 2(03): 170.
[http://dx.doi.org/10.4236/ojst.2012.23031]
[5]
Forouzanfar A. Clinical application of antibiotics for the management of periodontal disease, a systematic review. American J Pharm Sci 2015; 1(1): 39-44.
[6]
Eke PI, Thornton-Evans GO, Wei L, Borgnakke WS, Dye BA, Genco RJ. Periodontitis in US adults: National health and nutrition examination survey 2009-2014. J American Dental Assoc 2018; 149(7): 576-88.e6.
[7]
Cowan LT, Lakshminarayan K, Lutsey PL, et al. Periodontal disease and incident venous thromboembolism: The atherosclerosis risk in communities study. J Clin Periodontol 2019; 46(1): 12-9.
[http://dx.doi.org/10.1111/jcpe.13029] [PMID: 30362614]
[8]
Linden GJ, McClean KM, Woodside JV, et al. Antioxidants and periodontitis in 60-70-year-old men. J Clin Periodontol 2009; 36(10): 843-9.
[http://dx.doi.org/10.1111/j.1600-051X.2009.01468.x] [PMID: 19703237]
[9]
Wiebe CB, Putnins EE. The periodontal disease classification system of the American Academy of Periodontology--an update. J Can Dent Assoc 2000; 66(11): 594-7.
[PMID: 11253351]
[10]
Manjunath BC, Praveen K, Chandrashekar BR, Rani RM, Bhalla A. Periodontal infections: a risk factor for various systemic diseases. Natl Med J India 2011; 24(4): 214-9.
[PMID: 22208140]
[11]
Chandra Shekar BR, Nagarajappa R, Suma S, Thakur R. Herbal extracts in oral health care - A review of the current scenario and its future needs. Pharmacogn Rev 2015; 9(18): 87-92.
[http://dx.doi.org/10.4103/0973-7847.162101] [PMID: 26392704]
[12]
Williams RO, Feldmann M, Maini RN. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci USA 1992; 89(20): 9784-8.
[http://dx.doi.org/10.1073/pnas.89.20.9784]] [PMID: 1409699]
[13]
Moghaddam MA, Salehinejad J, Mokhtari MR, Mohammadipour HS, Forouzanfar A. Palatal peripheral ossifying fibroma along with generalized marginal gingivitis: a case report. American J Oral Med Radiol 2015; 2(4): 191-4.
[14]
Offenbacher S. Periodontal diseases: pathogenesis. Ann Periodontol 1996; 1(1): 821-78.
[http://dx.doi.org/10.1902/annals.1996.1.1.821] [PMID: 9118282]
[15]
Valkenburg C, Van der Weijden FA, Slot DE. Plaque control and reduction of gingivitis: The evidence for dentifrices. Periodontol 2000 2019; 79(1): 221-32.
[http://dx.doi.org/10.1111/prd.12257] [PMID: 30892760]
[16]
Waddington RJ, Moseley R, Embery G. Reactive oxygen species: a potential role in the pathogenesis of periodontal diseases. Oral Dis 2000; 6(3): 138-51.
[http://dx.doi.org/10.1111/j.1601-0825.2000.tb00325.x] [PMID: 10822357]
[17]
Muñoz-Carrillo JL, Hernández-Reyes VE, García-Huerta OE, et al. Pathogenesis of Periodontal Disease Periodontal Disease-Diagnose Considerations: IntechOpen 2019.
[18]
Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005; 366(9499): 1809-20.
[http://dx.doi.org/10.1016/S0140-6736(05)67728-8] [PMID: 16298220]
[19]
Ramesh A, Varghese SS, Doraiswamy JN, Malaiappan S. Herbs as an antioxidant arsenal for periodontal diseases. J Intercult Ethnopharmacol 2016; 5(1): 92-6.
[http://dx.doi.org/10.5455/jice.20160122065556] [PMID: 27069730]
[20]
Nugala B, Namasi A, Emmadi P, Krishna PM. Role of green tea as an antioxidant in periodontal disease: The Asian paradox. J Indian Soc Periodontol 2012; 16(3): 313-6.
[http://dx.doi.org/10.4103/0972-124X.100902] [PMID: 23162321]
[21]
Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 2014; 4: 177.
[http://dx.doi.org/10.3389/fphar.2013.00177] [PMID: 24454289]
[22]
Manju K, Jat R, Anju G. A review on medicinal plants used as a source of anticancer agents. International J Drug Res Technol 2017; 2(2): 6.
[23]
Chapple IL. Oxidative stress, nutrition and neutrogenomics in periodontal health and disease. Int J Dent Hyg 2006; 4(Suppl. 1): 15-21.
[http://dx.doi.org/10.1111/j.1601-5037.2006.00197.x] [PMID: 16965529]
[24]
Pulido-Moran M, Moreno-Fernandez J, Ramirez-Tortosa C, Ramirez-Tortosa M. Curcumin and health. Molecules 2016; 21(3): 264.
[http://dx.doi.org/10.3390/molecules21030264] [PMID: 26927041]
[25]
Forouzanfar F, Barreto G, Majeed M, Sahebkar A. Modulatory effects of curcumin on heat shock proteins in cancer: A promising therapeutic approach. Biofactors 2019; 45(5): 631-40.
[http://dx.doi.org/10.1002/biof.1522] [PMID: 31136038]
[26]
Mantzorou M, Pavlidou E, Vasios G, Tsagalioti E, Giaginis C. Effects of curcumin consumption on human chronic diseases: A narrative review of the most recent clinical data. Phytother Res 2018; 32(6): 957-75.
[http://dx.doi.org/10.1002/ptr.6037] [PMID: 29468820]
[27]
Marchiani A, Rozzo C, Fadda A, Delogu G, Ruzza P. Curcumin and curcumin-like molecules: from spice to drugs. Curr Med Chem 2014; 21(2): 204-22.
[http://dx.doi.org/10.2174/092986732102131206115810] [PMID: 23590716]
[28]
Mhillaj E, Tarozzi A, Pruccoli L, Cuomo V, Trabace L, Mancuso C. Curcumin and heme oxygenase: Neuroprotection and beyond. Int J Mol Sci 2019; 20(10): 2419.
[http://dx.doi.org/10.3390/ijms20102419] [PMID: 31100781]
[29]
Yang M, Akbar U, Mohan C. Curcumin in autoimmune and rheumatic diseases. Nutrients 2019; 11(5): 1004.
[http://dx.doi.org/10.3390/nu11051004] [PMID: 31052496]
[30]
Cicero AFG, Colletti A, Bajraktari G, et al. Lipid-lowering nutraceuticals in clinical practice: Position paper from an International Lipid Expert Panel. Nutr Rev 2017; 75(9): 731-67.
[http://dx.doi.org/10.1093/nutrit/nux047] [PMID: 28938795]
[31]
Menon VP, Sudheer AR. Antioxidant and anti-inflammatory properties of curcumin The molecular targets and therapeutic uses of curcumin in health and disease Springer 2007; 105-25.
[32]
De R, Kundu P, Swarnakar S, et al. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob Agents Chemother 2009; 53(4): 1592-7.
[http://dx.doi.org/10.1128/AAC.01242-08] [PMID: 19204190]
[33]
Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Altern Complement Med 2003; 9(1): 161-8.
[http://dx.doi.org/10.1089/107555303321223035] [PMID: 12676044]
[34]
Abdollahi E, Momtazi AA, Johnston TP, Sahebkar A. Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades? J Cell Physiol 2018; 233(2): 830-48.
[http://dx.doi.org/10.1002/jcp.25778] [PMID: 28059453]
[35]
Karimian MS, Pirro M, Majeed M, Sahebkar A. Curcumin as a natural regulator of monocyte chemoattractant protein-1. Cytokine Growth Factor Rev 2017; 33: 55-63.
[http://dx.doi.org/10.1016/j.cytogfr.2016.10.001] [PMID: 27743775]
[36]
Mollazadeh H, Cicero AFG, Blesso CN, Pirro M, Majeed M, Sahebkar A. Immune modulation by curcumin: The role of interleukin-10. Crit Rev Food Sci Nutr 2019; 59(1): 89-101.
[http://dx.doi.org/10.1080/10408398.2017.1358139] [PMID: 28799796]
[37]
Panahi Y, Kianpour P, Mohtashami R, Jafari R, Simental-Mendía LE, Sahebkar A. Efficacy and safety of phytosomal curcumin in non-alcoholic fatty liver disease: A randomized controlled trial. Drug Res (Stuttg) 2017; 67(4): 244-51.
[http://dx.doi.org/10.1055/s-0043-100019] [PMID: 28158893]
[38]
Matsushita Y, Ueda H. Curcumin blocks chronic morphine analgesic tolerance and brain-derived neurotrophic factor upregulation. Neuroreport 2009; 20(1): 63-8.
[http://dx.doi.org/10.1097/WNR.0b013e328314decb] [PMID: 19033880]
[39]
Sahebkar A. Molecular mechanisms for curcumin benefits against ischemic injury. Fertil Steril 2010; 94(5): e75-6.
[http://dx.doi.org/10.1016/j.fertnstert.2010.07.1071] [PMID: 20797714]
[40]
Park J, Conteas CN. Anti-carcinogenic properties of curcumin on colorectal cancer. World J Gastrointest Oncol 2010; 2(4): 169-76.
[http://dx.doi.org/10.4251/wjgo.v2.i4.169] [PMID: 21160593]
[41]
Rezaee R, Momtazi AA, Monemi A, Sahebkar A. Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity. Pharmacol Res 2017; 117: 218-27.
[http://dx.doi.org/10.1016/j.phrs.2016.12.037] [PMID: 28042086]
[42]
Iranshahi M, Sahebkar A, Hosseini ST, Takasaki M, Konoshima T, Tokuda H. Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo. Phytomedicine 2010; 17(3-4): 269-73.
[http://dx.doi.org/10.1016/j.phymed.2009.05.020] [PMID: 19577457]
[43]
Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J 2013; 15(1): 195-218.
[http://dx.doi.org/10.1208/s12248-012-9432-8] [PMID: 23143785]
[44]
Hewlings SJ, Kalman DS. Curcumin: a review of it’s effects on human health. Foods 2017; 6(10): 92.
[http://dx.doi.org/10.3390/foods6100092] [PMID: 29065496]
[45]
Cochran DL. Inflammation and bone loss in periodontal disease. J Periodontol 2008; 79(8)(Suppl.): 1569-76.
[http://dx.doi.org/10.1902/jop.2008.080233] [PMID: 18673012]
[46]
Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999; 20(3): 345-57.
[http://dx.doi.org/10.1210/edrv.20.3.0367] [PMID: 10368775]
[47]
Kirkwood KL, Cirelli JA, Rogers JE, Giannobile WV. Novel host response therapeutic approaches to treat periodontal diseases. Periodontol 2000 2007; 43(1): 294-315.
[http://dx.doi.org/10.1111/j.1600-0757.2006.00166.x] [PMID: 17214846]
[48]
Crotti T, Smith MD, Hirsch R, et al. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J Periodontal Res 2003; 38(4): 380-7.
[http://dx.doi.org/10.1034/j.1600-0765.2003.00615.x] [PMID: 12828654]
[49]
Liu YCG, Lerner UH, Teng YTA. Cytokine responses against periodontal infection: protective and destructive roles. Periodontol 2000 2010; 52(1): 163-206.
[http://dx.doi.org/10.1111/j.1600-0757.2009.00321.x] [PMID: 20017801]
[50]
Kawai T, Matsuyama T, Hosokawa Y, et al. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol 2006; 169(3): 987-98.
[http://dx.doi.org/10.2353/ajpath.2006.060180] [PMID: 16936272]
[51]
Zhou T, Chen D, Li Q, Sun X, Song Y, Wang C. Curcumin inhibits inflammatory response and bone loss during experimental periodontitis in rats. Acta Odontol Scand 2013; 71(2): 349-56.
[http://dx.doi.org/10.3109/00016357.2012.682092] [PMID: 22554269]
[52]
DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 1997; 388(6642): 548-54.
[http://dx.doi.org/10.1038/41493] [PMID: 9252186]
[53]
Milward MR, Chapple IL, Wright HJ, Millard JL, Matthews JB, Cooper PR. Differential activation of NF-kappaB and gene expression in oral epithelial cells by periodontal pathogens. Clin Exp Immunol 2007; 148(2): 307-24.
[http://dx.doi.org/10.1111/j.1365-2249.2007.03342.x] [PMID: 17355248]
[54]
Carayol N, Chen J, Yang F, et al. A dominant function of IKK/NFkappaB signaling in global lipopolysaccharide-induced gene expression. J Biol Chem 2006; 281(41): 31142-51.
[http://dx.doi.org/10.1074/jbc.M603417200] [PMID: 16914552]
[55]
Ambili R, Janam P. A critique on nuclear factor-kappa B and signal transducer and activator of transcription 3: The key transcription factors in periodontal pathogenesis. J Indian Soc Periodontol 2017; 21(5): 350-6.
[PMID: 29491579]
[56]
Lai JL, Liu YH, Liu C, et al. Indirubin inhibits LPS-induced inflammation via TLR4 abrogation mediated by the NF-kB and MAPK signaling pathways. Inflammation 2017; 40(1): 1-12.
[http://dx.doi.org/10.1007/s10753-016-0447-7] [PMID: 27718095]
[57]
Nussbaum G, Ben-Adi S, Genzler T, Sela M, Rosen G. Involvement of Toll-like receptors 2 and 4 in the innate immune response to Treponema denticola and its outer sheath components. Infect Immun 2009; 77(9): 3939-47.
[http://dx.doi.org/10.1128/IAI.00488-09] [PMID: 19596768]
[58]
Verdrengh M, Bokarewa M, Ohlsson C, Stolina M, Tarkowski A. RANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis. Bone 2010; 46(3): 752-8.
[http://dx.doi.org/10.1016/j.bone.2009.10.028] [PMID: 19879986]
[59]
Abu-Amer Y. NF-kappaB signaling and bone resorption. Osteoporosis Int: A journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2013; 24(9): 2377-86.
[60]
Shapira L, Borinski R, Sela MN, Soskolne A. Superoxide formation and chemiluminescence of peripheral polymorphonuclear leukocytes in rapidly progressive periodontitis patients. J Clin Periodontol 1991; 18(1): 44-8.
[http://dx.doi.org/10.1111/j.1600-051X.1991.tb01118.x] [PMID: 1646239]
[61]
Marquis RE. Oxygen metabolism, oxidative stress and acid-base physiology of dental plaque biofilms. J Ind Microbiol 1995; 15(3): 198-207.
[http://dx.doi.org/10.1007/BF01569826] [PMID: 8519478]
[62]
Borba TT, Molz P, Schlickmann DS, et al. Periodontitis: Genomic instability implications and associated risk factors. Mutat Res Genet Toxicol Environ Mutagen 2019; 840: 20-3.
[http://dx.doi.org/10.1016/j.mrgentox.2019.01.005] [PMID: 30857729]
[63]
Chopra A, Sivaraman K. An update on possible pathogenic mechanisms of periodontal pathogens on renal dysfunction. Crit Rev Microbiol 2019; 45(5-6): 514-38.
[http://dx.doi.org/10.1080/1040841X.2018.1553847] [PMID: 30729832]
[64]
Torres MA, Jones JD, Dangl JL. Reactive oxygen species signaling in response to pathogens. Plant Physiol 2006; 141(2): 373-8.
[http://dx.doi.org/10.1104/pp.106.079467] [PMID: 16760490]
[65]
Roos D, van Bruggen R, Meischl C. Oxidative killing of microbes by neutrophils. Microbes Infect 2003; 5(14): 1307-15.
[http://dx.doi.org/10.1016/j.micinf.2003.09.009] [PMID: 14613774]
[66]
Tamaki N, Hayashida H, Fukui M, et al. Oxidative stress and antibody levels to periodontal bacteria in adults: the Nagasaki Islands study. Oral Dis 2014; 20(3): e49-56.
[http://dx.doi.org/10.1111/odi.12127] [PMID: 23679350]
[67]
Baltacıoğlu E, Yuva P, Aydın G, et al. Lipid peroxidation levels and total oxidant/antioxidant status in serum and saliva from patients with chronic and aggressive periodontitis. Oxidative stress index: a new biomarker for periodontal disease? J Periodontol 2014; 85(10): 1432-41.
[http://dx.doi.org/10.1902/jop.2014.130654] [PMID: 24635543]
[68]
Dahiya P, Kamal R, Gupta R, Bhardwaj R, Chaudhary K, Kaur S. Reactive oxygen species in periodontitis. J Indian Soc Periodontol 2013; 17(4): 411-6.
[http://dx.doi.org/10.4103/0972-124X.118306] [PMID: 24174716]
[69]
Gan P, Gao Z, Zhao X, Qi G. Surfactin inducing mitochondriadependent ROS to activate MAPKs, NF-κB and inflammasomes in macrophages for adjuvant activity. Sci Rep 2016; 6: 39303.
[http://dx.doi.org/10.1038/srep39303] [PMID: 27966632]
[70]
Sho T, Xu J. Role and mechanism of ROS scavengers in alleviating NLRP3-mediated inflammation. Biotechnol Appl Biochem 2019; 66(1): 4-13.
[http://dx.doi.org/10.1002/bab.1700] [PMID: 30315709]
[71]
Liu W, Gu J, Qi J, et al. Lentinan exerts synergistic apoptotic effects with paclitaxel in A549 cells via activating ROS-TXNIPNLRP3 inflammasome. J Cell Mol Med 2015; 19(8): 1949-55.
[http://dx.doi.org/10.1111/jcmm.12570] [PMID: 25858687]
[72]
Kanzaki H, Shinohara F, Kajiya M, Kodama T. The Keap1/Nrf2 protein axis plays a role in osteoclast differentiation by regulating intracellular reactive oxygen species signaling. J Biol Chem 2013; 288(32): 23009-20.
[http://dx.doi.org/10.1074/jbc.M113.478545] [PMID: 23801334]
[73]
Hu P, Huang P, Chen MW. Curcumin attenuates cyclooxygenase-2 expression via inhibition of the NF-κB pathway in lipopolysaccharide-stimulated human gingival fibroblasts. Cell Biol Int 2013; 37(5): 443-8.
[http://dx.doi.org/10.1002/cbin.10050] [PMID: 23494805]
[74]
Lubbad A, Oriowo MA, Khan I. Curcumin attenuates inflammation through inhibition of TLR-4 receptor in experimental colitis. Mol Cell Biochem 2009; 322(1-2): 127-35.
[http://dx.doi.org/10.1007/s11010-008-9949-4] [PMID: 19002562]
[75]
Kim G-Y, Kim K-H, Lee S-H, et al. Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-κ B as potential targets. J Immunol 2005; 174(12): 8116-24.
[http://dx.doi.org/10.4049/jimmunol.174.12.8116] [PMID: 15944320]
[76]
Mun SH, Kim HS, Kim JW, et al. Oral administration of curcumin suppresses production of matrix metalloproteinase (MMP)-1 and MMP-3 to ameliorate collagen-induced arthritis: inhibition of the PKCdelta/JNK/c-Jun pathway. J Pharmacol Sci 2009; 111(1): 13-21.
[http://dx.doi.org/10.1254/jphs.09134FP] [PMID: 19763044]
[77]
Boyanapalli SSS, Huang Y, Su Z, et al. Pharmacokinetics and Pharmacodynamics of Curcumin in regulating anti-inflammatory and epigenetic gene expression. Biopharm Drug Dispos 2018; 39(6): 289-97.
[http://dx.doi.org/10.1002/bdd.2136] [PMID: 29870054]
[78]
Chandrasekaran CV, Sundarajan K, Edwin JR, Gururaja GM, Mundkinajeddu D, Agarwal A. Immune-stimulatory and antiinflammatory activities of Curcuma longa extract and its polysaccharide fraction. Pharmacognosy Res 2013; 5(2): 71-9.
[http://dx.doi.org/10.4103/0974-8490.110527] [PMID: 23798880]
[79]
Sajithlal GB, Chithra P, Chandrakasan G. Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats. Biochem Pharmacol 1998; 56(12): 1607-14.
[http://dx.doi.org/10.1016/S0006-2952(98)00237-8] [PMID: 9973181]
[80]
Sidhu GS, Singh AK, Thaloor D, et al. Enhancement of wound healing by curcumin in animals. Wound Repair Regen 1998; 6(2): 167-77.
[http://dx.doi.org/10.1046/j.1524-475X.1998.60211.x] [PMID: 9776860]
[81]
Corrêa MG, Pires PR, Ribeiro FV, et al. Systemic treatment with resveratrol and/or curcumin reduces the progression of experimental periodontitis in rats. J Periodontal Res 2017; 52(2): 201-9.
[http://dx.doi.org/10.1111/jre.12382] [PMID: 27135637]
[82]
Gu Y, Lee H-M, Napolitano N, et al. 4-methoxycarbonyl curcumin: a unique inhibitor of both inflammatory mediators and periodontal inflammation. Mediators Inflamm 2013; 2013: 329740.
[83]
Guimarães MR, Coimbra LS, de Aquino SG, Spolidorio LC, Kirkwood KL, Rossa C Jr. Potent anti-inflammatory effects of systemically administered curcumin modulate periodontal disease in vivo. J Periodontal Res 2011; 46(2): 269-79.
[http://dx.doi.org/10.1111/j.1600-0765.2010.01342.x] [PMID: 21306385]
[84]
Guimarães MR, de Aquino SG, Coimbra LS, Spolidorio LC, Kirkwood KL, Rossa C Jr. Curcumin modulates the immune response associated with LPS-induced periodontal disease in rats. Innate Immun 2012; 18(1): 155-63.
[http://dx.doi.org/10.1177/1753425910392935] [PMID: 21242275]
[85]
Mau L-P, Cheng W-C, Chen J-K, Shieh Y-S, Cochran DL, Huang R-Y. Curcumin ameliorates alveolar bone destruction of experimental periodontitis by modulating osteoclast differentiation, activation and function. J Funct Foods 2016; 22: 243-56.
[http://dx.doi.org/10.1016/j.jff.2016.01.025]
[86]
Zambrano LMG, Brandao DA, Rocha FRG, et al. Local administration of curcumin-loaded nanoparticles effectively inhibits inflammation and bone resorption associated with experimental periodontal disease. Sci Rep 2018; 8(1): 6652.
[http://dx.doi.org/10.1038/s41598-018-24866-2] [PMID: 29703905]
[87]
Hosadurga RR, Rao SN, Jose J, Rompicharla NC, Shakil M, Shashidhara R. Evaluation of the efficacy of 2% curcumin gel in the treatment of experimental periodontitis. Pharmacognosy Res 2014; 6(4): 326-33.
[http://dx.doi.org/10.4103/0974-8490.138287] [PMID: 25276071]
[88]
Guimaraes-Stabili MR, de Aquino SG, de Almeida Curylofo F, et al. Systemic administration of curcumin or piperine enhances the periodontal repair: a preliminary study in rats. Clin Oral Investig 2019; 23(8): 3297-306.
[http://dx.doi.org/10.1007/s00784-018-2755-9] [PMID: 30498979]
[89]
Anitha V, Rajesh P, Shanmugam M, Priya BM, Prabhu S, Shivakumar V. Comparative evaluation of natural curcumin and synthetic chlorhexidine in the management of chronic periodontitis as a local drug delivery: A clinical and microbiological study. Indian J Dent Res 2015; 26(1): 53-6.
[http://dx.doi.org/10.4103/0970-9290.156806] [PMID: 25961616]
[90]
Anuradha BR, Bai YD, Sailaja S, Sudhakar J, Priyanka M, Deepika V. Evaluation of anti-inflammatory effects of curcumin gel as an adjunct to scaling and root planing: a clinical study. J Int Oral Health 2015; 7(7): 90-3.
[PMID: 26229378]
[91]
Arunachalam LT, Sudhakar U, Vasanth J, Khumukchum S, Selvam VV. Comparison of anti-plaque and anti-gingivitis effect of curcumin and chlorhexidine mouth rinse in the treatment of gingivitis: A clinical and biochemical study. J Indian Soc Periodontol 2017; 21(6): 478-83.
[PMID: 29551867]
[92]
Bhatia M, Urolagin SS, Pentyala KB, Urolagin SB. K B M, Bhoi S. Novel therapeutic approach for the treatment of periodontitis by curcumin. J Clin Diagn Res 2014; 8(12): ZC65-9.
[http://dx.doi.org/10.7860/JCDR/2014/8231.5343] [PMID: 25654035]
[93]
Chatterjee A, Debnath K, Rao NKH. A comparative evaluation of the efficacy of curcumin and chlorhexidine mouthrinses on clinical inflammatory parameters of gingivitis: A double-blinded randomized controlled clinical study. J Indian Soc Periodontol 2017; 21(2): 132-7.
[http://dx.doi.org/10.4103/jisp.jisp_136_17] [PMID: 29398858]
[94]
Gottumukkala SN, Koneru S, Mannem S, Mandalapu N. Effectiveness of sub gingival irrigation of an indigenous 1% curcumin solution on clinical and microbiological parameters in chronic periodontitis patients: A pilot randomized clinical trial. Contemp Clin Dent 2013; 4(2): 186-91.
[http://dx.doi.org/10.4103/0976-237X.114874] [PMID: 24015007]
[95]
Gottumukkala SN, Sudarshan S, Mantena SR. Comparative evaluation of the efficacy of two controlled release devices: Chlorhexidine chips and indigenous curcumin based collagen as local drug delivery systems. Contemp Clin Dent 2014; 5(2): 175-81.
[http://dx.doi.org/10.4103/0976-237X.132310] [PMID: 24963242]
[96]
Guru SR, Kothiwale SV, Saroch N, Guru RC. Comparative evaluation of inhibitory effect of curcumin and doxycycline on matrix metalloproteinase-9 activity in chronic periodontitis. Indian J Dent Res 2017; 28(5): 560-5.
[http://dx.doi.org/10.4103/ijdr.IJDR_461_16] [PMID: 29072221]
[97]
Hugar SS, Patil S, Metgud R, Nanjwade B, Hugar SM. Influence of application of chlorhexidine gel and curcumin gel as an adjunct to scaling and root planing: A interventional study. J Nat Sci Biol Med 2016; 7(2): 149-54.
[http://dx.doi.org/10.4103/0976-9668.184701] [PMID: 27433065]
[98]
Muglikar S, Patil KC, Shivswami S, Hegde R. Efficacy of curcumin in the treatment of chronic gingivitis: a pilot study. Oral Health Prev Dent 2013; 11(1): 81-6.
[PMID: 23507685]
[99]
Nagasri M, Madhulatha M, Musalaiah SV, Kumar PA, Krishna CH, Kumar PM. Efficacy of curcumin as an adjunct to scaling and root planning in chronic periodontitis patients: A clinical and microbiological study. J Pharm Bioallied Sci 2015; 7(Suppl. 2): S554-8.
[http://dx.doi.org/10.4103/0975-7406.163537] [PMID: 26538916]
[100]
Nasra MM, Khiri HM, Hazzah HA, Abdallah OY. Formulation, invitro characterization and clinical evaluation of curcumin in-situ gel for treatment of periodontitis. Drug Deliv 2017; 24(1): 133-42.
[http://dx.doi.org/10.1080/10717544.2016.1233591] [PMID: 28156166]
[101]
Pulikkotil SJ, Nath S. Effects of curcumin on crevicular levels of IL-1β and CCL28 in experimental gingivitis. Aust Dent J 2015; 60(3): 317-27.
[http://dx.doi.org/10.1111/adj.12340] [PMID: 26219195]
[102]
Ravishankar PL, Kumar YP, Anila EN, Chakraborty P, Malakar M, Mahalakshmi R. Effect of local application of curcumin and ornidazole gel in chronic periodontitis patients. Int J Pharm Investig 2017; 7(4): 188-92.
[http://dx.doi.org/10.4103/jphi.JPHI_82_17] [PMID: 29692978]
[103]
Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm 2007; 4(6): 807-18.
[http://dx.doi.org/10.1021/mp700113r] [PMID: 17999464]
[104]
Tønnesen HH, Másson M, Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm 2002; 244(1-2): 127-35.
[http://dx.doi.org/10.1016/S0378-5173(02)00323-X] [PMID: 12204572]
[105]
Tomren MA, Másson M, Loftsson T, Tønnesen HH. Studies on curcumin and curcuminoids XXXI. Symmetric and asymmetric curcuminoids: stability, activity and complexation with cyclodextrin. Int J Pharm 2007; 338(1-2): 27-34.
[http://dx.doi.org/10.1016/j.ijpharm.2007.01.013] [PMID: 17298869]
[106]
Prasad S, Tyagi AK, Aggarwal BB. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice Cancer research and treatment: official journal of Korean Cancer Association 2014; 46(1): 2.
[http://dx.doi.org/10.4143/crt.2014.46.1.2]
[107]
Zhang Y. M Golub L, Johnson F, Wishnia A. pKa, zinc-and serum albumin-binding of curcumin and two novel biologically-active chemically-modified curcumins. Curr Med Chem 2012; 19(25): 4367-75.
[http://dx.doi.org/10.2174/092986712802884240] [PMID: 22830351]
[108]
Zhang Y, Gu Y, Lee H-M, et al. Design, synthesis and biological activity of new polyenolic inhibitors of matrix metalloproteinases: a focus on chemically-modified curcumins. Curr Med Chem 2012; 19(25): 4348-58.
[http://dx.doi.org/10.2174/092986712802884295] [PMID: 22830350]
[109]
Khalil NM, do Nascimento TCF, Casa DM, et al. Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats. Colloids Surf B Biointerfaces 2013; 101: 353-60.
[http://dx.doi.org/10.1016/j.colsurfb.2012.06.024] [PMID: 23010041]
[110]
Paka GD, Ramassamy C. Optimization of curcumin-loaded PEGPLGA nanoparticles by GSH functionalization: investigation of the internalization pathway in neuronal cells. Mol Pharm 2017; 14(1): 93-106.
[http://dx.doi.org/10.1021/acs.molpharmaceut.6b00738] [PMID: 27744707]
[111]
Garala K, Joshi P, Shah M, Ramkishan A, Patel J. Formulation and evaluation of periodontal in situ gel. Int J Pharm Investig 2013; 3(1): 29-41.
[http://dx.doi.org/10.4103/2230-973X.108961] [PMID: 23799203]
[112]
Sakima VT, Barbugli PA, Cerri PS, et al. Antimicrobial photodynamic therapy mediated by curcumin-loaded polymeric nanoparticles in a murine model of oral candidiasis. Molecules 2018; 23(8): 2075.
[http://dx.doi.org/10.3390/molecules23082075] [PMID: 30126245]